EREmma Raitoharju

Emma Raitoharju

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Emma Raitoharju has a total of 276 co-authors. Here are the top co-authors by number of shared publications:

  • Terho Lehtimäki

    Department of Clinical Chemistry, Fimlab Laboratories, and Finnish Cardiovascular Research Center - Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland

    12 shared publications
  • Saara Marttila

    Molecular Epidemiology (MOLE), Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland

    11 shared publications
  • Pashupati Prasad Mishra

    Department of Clinical Chemistry, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland

    9 shared publications
  • Mika Kähönen

    Department of Clinical Physiology, Tampere University Hospital and Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland

    8 shared publications
  • Olli Raitakari

    Centre for Population Health Research, University of Turku and Turku University Hospital, Turku, Finland

    8 shared publications
  • Saara Marttila

    Molecular Epidemiology (MOLE), Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland

    7 shared publications

Latest Publications

  • Open Access

    Male youth BMI is associated with epigenetic ageing of female descendants but not blood or sperm DNA methylation

    by Jo Ciantar, Saara Marttila, Ilari Taskinen, Virva Liski, Noora Kartiosuo, Damien Kaukonen, Pashupati P. Mishra, Leo-Pekka Lyytikäinen, Suvi Rovio, Juha Mykkänen, et al.

    Studies based on harvest records indicate that grandparental nutrition in youth is associated with the health traits of grandchildren in a sex-specific lineage. We investigated whether male early adulthood anthropometrics associate with epigenetic age, a measure of general well-being, and DNA methylation, a potential molecular inheritance mechanism, in three generations of descendants. Data on weight, height, BMI and chest circumference measured at military draft examinations (at age 18–24 yrs.) were retrieved from national archives for 1,013 men, herein referred to as Generation Archives (G A ). The genome-wide DNA methylation of their descendants participating in the Young Finns Study (YFS) was measured from the blood and sperm from the children (59–80 yrs., n blood = 362, n sperm = 51), grandchildren (34–49 yrs., n blood = 421, n sperm = 98) and great-grandchildren (7–30 yrs., n blood = 200). The men’s (G A ) BMI had an inverse association with the epigenetic pace of ageing (DunedinPACE) of their daughters (β = −0.01, p = 0.002, n = 169) and the daughters’ daughters (β = −0.01, p = 0.049, n = 126) but not with that of their male descendants. From within the YFS cohort, maternal, but not paternal, BMI at ages 13–34 also had an inverse association with the DunedinPACE of the immediate offspring. However, robust evidence for the inheritance mechanism was not found in the analyses between the anthropometric measurements of the G A men and the DNA methylation profiles in the blood and sperm of their descendants.

  • Open Access

    BMI Deviations from Genetic Prediction Are Associated with Distinct Molecular Signatures in Finnish Population Cohorts

    by Tianyu Zhu, Gabin Drouard, Aino Heikkinen, Mikaela Hukkanen, Teemu Palviainen, Bram J. Berntzen, Leo-Pekka Lyytikäinen, Emma Raitoharju, Kirsi H. Pietiläinen, Terho Lehtimäki, et al.

    Objective: Polygenic risk scores (PRS) estimate genetically predicted BMI, but lifestyle and environmental factors may cause deviations between observed and predicted BMI. We investigated whether such deviations are associated with distinct molecular profiles and whether these differ by direction of deviation. Methods: We analyzed 2,508 adults from the Finnish Twin Cohort and 1,715 from the Young Finns Study with clinical, metabolomic, DNA methylation, and proteomic data. PRS-informed residual BMI (rBMI) quantified deviations between observed and genetically predicted BMI. Associations between rBMI and multi-omic profiles were assessed using linear mixed-effects models with a hinge term to compare effects above vs. below genetic prediction. Twin analyses further accounted for shared genetic and environmental factors. Results: rBMI is associated with distinct cardiometabolic and molecular profiles depending on whether BMI is above or below genetic prediction. When BMI exceeds genetic prediction, rBMI shows stronger associations with inflammatory and cardiovascular markers. In contrast, several metabolites and plasma proteins show stronger associations when BMI is below genetic prediction. Epigenetic aging increases with higher rBMI regardless of direction. Similar patterns are observed in BMI-discordant twin pairs. Conclusion: Deviations from genetically predicted BMI are associated with distinct clinical and molecular signatures beyond absolute BMI alone.

  • Open Access

    Intergenerational and life-course links between a cardiovascular health-related methylation score and early vascular changes

    by Binisha H. Mishra, Emma Raitoharju, Leo-Pekka Lyytikäinen, Nina Mononen, Juhani S. Koskinen, Jorma Viikari, Katja Pahkala, Suvi Rovio, Juha Mykkänen, Markus Juonala, et al.

    Background: DNA methylation (DNAm) may capture cumulative genetic, environmental, and lifestyle influences on cardiovascular health. Composite DNAm score based on the American Heart Association Life’s Essential 8 (LE8) framework have been linked to clinical events, but their association with early vascular changes and intergenerational effects is unclear. Methods: We studied up to 1432 participants from the multigenerational Young Finns Study (YFS-3G), including parents (G0) and adult offspring (G1). DNAm was measured using Illumina EPIC arrays in 2011 and/or 2018, and carotid intima–media thickness (cIMT) was assessed in 2018. The LE8 DNAm score was calculated as a weighted sum of methylation levels. Associations with cIMT were evaluated in intergenerational, prospective, and cross-sectional settings, adjusting for demographic, technical, and biological covariates and conventional cardiovascular risk factors. Results: Higher parental LE8 DNAm score was associated with lower offspring cIMT (β = −0.022 mm/SD; p-value = 0.02), although the association was attenuated after adjustment for parental cardiovascular risk factors. In G1, a higher baseline DNAm score was associated with lower cIMT measured seven years later (β = −0.030 mm/SD; p-value = 1.1 × 10⁻⁵). This association remained significant after adjustment for follow-up cardiovascular risk factors (p-value=0.009) but not after additional adjustment for prior cIMT. Cross-sectionally, higher DNAm score was associated with lower cIMT in both generations, with attenuation after risk factor adjustment in G1 but not G0. Associations with carotid plaque were not significant. Genes associated with the DNAm score were enriched for immune and inflammatory pathways. Conclusions: An LE8-derived DNAm score was associated with lower cIMT across the life course and, to a lesser extent, across generations. These findings suggest that blood DNAm reflects cumulative cardiovascular health and vascular burden and may complement conventional cardiovascular risk assessment.

  • Open Access

    The length of the embryo culture in assisted reproductive technology does not have a major impact on newborn DNA methylation

    by Jo Ciantar, Emma Raitoharju, Saara Marttila, Terho Lehtimäki, Eeva-Maria Pohjonen, Katja Ahinko, Noora Kaartinen

    Blastocyst culture is an essential part of IVF/ICSI treatments, however, it has been shown to increase the risk of preterm deliveries as well as large for gestational age infants. The effect of the extended culture on offspring phenotype is thought to be mediated by epigenetic mechanisms, since this developmental period coincides with extensive epigenetic remodelling. Here, we compare genome-wide DNA methylation of cord blood and umbilical cord artery samples collected from newborns resulting from cleavage-stage transfer (n = 25), blastocyst-stage transfer (n = 25), and spontaneous conception (n = 30). Epigenome-wide association studies, global methylation analyses, and epigenetic age comparison did not reveal statistically significant differences between the cleavage-stage and blastocyst-stage groups. However, we identified some loci with a >10% difference in median methylation level between the groups, which should be studied further with a larger sample size. The genome-wide DNA methylation of spontaneously conceived and cleavage-stage newborns were comparable while in the spontaneous to blastocyst-stage comparison, cg25263722 was differentially methylated (P = 5 × 10−8) in umbilical cord artery. Our study did not identify major effects of extended culture on DNA methylation, which is reassuring with respect to the future health of newborns conceived via assisted reproductive technologies.

  • Open Access

    Trans -eQTLs reveal the architecture of human gene regulatory networks

    by C.A. Robert Warmerdam, Harm-Jan Westra, Adriaan van der Graaf, Marc Jan Bonder, Patrick Deelen, Tijs van Lieshout, Anke Jannie Landman, Mihkel Jesse, Benjamin J. Strober, Toni Boltz, et al.

    Many non-coding variants influence complex traits and diseases through gene regulation, yet the mechanisms linking these variants to downstream biology remain poorly understood. Here, we present eQTLGen Phase 2 , a comprehensive genome-wide analysis of gene expression quantitative trait loci (eQTLs) in 43,301 blood samples from 52 datasets. Beyond local cis -effects, this sample size enabled the first systematic mapping of trans -eQTLs at scale. We identify cis -eQTLs for nearly all expressed genes (94.7%) and trans -eQTLs for over half (56.2%). Second, by colocalizing cis -eQTLs with trans -eQTLs, we infer a directed gene regulatory network comprising 47,554 directed gene regulatory relationships. These networks reveal how genetic perturbations in upstream regulators produce dose-dependent downstream effects, supported by Perturb-seq and ChIP-seq data. Third, integrating this network with 87 genome-wide association studies allows us to systematically prioritize trait-relevant pathways and candidate genes. Variants exerting both cis – and trans -effects are markedly more likely to colocalize with trait associations than cis -only variants, delineating a subset of functionally active cis -eQTLs from a large group with limited downstream impact. This distinction provides a conceptual framework for identifying regulatory variants that truly mediate complex trait biology. Together, these results provide a publicly available resource of cis – and trans -eQTLs and an in vivo scaffold for human gene-regulatory networks, elucidating how propagation of cis -effects modulates complex disease.


  • Open Access

    Genome-wide DNA methylation patterns for indicators of liver steatosis: a longitudinal multiomic study

    by Jo Ciantar, Sonja Rajić, Daria Kostiniuk, Ella Raulamo, Noora Kartiosuo, Liye Lai, Pashupati P. Mishra, Leo-Pekka Lyytikäinen, Marcus E. Kleber, Suvi Rovio, et al.

    Background: To identify blood DNA methylation profiles related to liver steatosis, we performed an EWAS on the presence of ultrasonically-identified liver steatosis in the Young Finns Study (YFS) participants (n = 1529, 33–50y.), and on liver enzyme levels and fatty liver index (FLI) across three discovery cohorts: YFS, LURIC (n = 2371, 17–92y.) and KORA FF4 (n = 1872, 39–88y.). We further investigated the discovered associations across the longitudinal subset of YFS (n = 255), encompassing three follow-ups over 32 years, and the three-generational YFS-3G follow-up in 2018–2020. Finally, we examined the associations of the discovered CpGs with nearby genetic variation and whole blood expression of nearby genes. Results: In YFS, the methylation levels of cg06690548 ( SLC7A11 ) were lower in individuals with liver steatosis (Δbeta = − 0.011, FDR = 0.004). Methylation of 9 CpGs associated with GGT and 23 CpGs with FLI in at least two of the discovery cohorts. Methylation at cg06690548 ( SLC7A11 ) and the majority of the CpGs associating with GGT or FLI had the strongest association in the two oldest generations of YFS-3G follow-up (ages 43–59y. and 59–93y.), with minor or non-significant association in the youngest generation (ages 6–36y.). Discovered meQTLs for the CpGs did not modulate the association between the methylation levels and GGT or FLI. The expression of the nearby genes mediated only the association between cg06500161 ( ABCG1 ) and cg20544516 ( SREBF1 ) and FLI. Conclusions: Our findings highlight the association between the methylation levels of cg06690548 ( SLC7A11) and liver steatosis, describe the dynamic relationship between whole blood DNA methylation and MASLD, and contribute to a deeper understanding of the pathophysiology of liver diseases.


  • Open Access

    Complement expression in human atherosclerotic plaques and blood cells in patients with coronary artery disease

    by Eero Teppo, A. Inkeri Lokki, Emma Raitoharju, Harlan Barker, Pashupati P. Mishra, Saara Marttila, Jaakko Laaksonen, Leo-Pekka Lyytikäinen, Nina Mononen, Ivana Kholová, et al.

    Background Inflammatory processes are a key cause of atherosclerosis and cardiovascular diseases. Complement system has been implicated but evidence is less clear. We tested whether atherosclerosis severity, plaque types, and vascular region are associated with mRNA expression of genes encoding proteins of the complement system and investigated the cell-specific expression of the most differentially expressed transcripts in plaque macrophages, fibroblasts, and endothelial, smooth muscle, Schwann, mast, plasma, T-, and B-cells. Methods Total mRNA was isolated, and gene expression analyzed from 29 carotid, 15 abdominal aortic, and 24 femoral plaque samples, and 28 atherosclerosis-free control left internal thoracic artery samples of 95 patients, as well as from 97 whole blood and 97 peripheral mononuclear cell samples of 97 patients. Genome-wide transcriptomic analyses were done using RNA bead microarray platforms. Differential expression was compared between plaques with normal arteries, unstable with stable plaques, as well as CAD patients with CAD-free patients. Results A total of 33 out of 90 (37%) transcripts of the complement system were differentially expressed in atherosclerotic plaques as compared to histologically normal arteries. In aortic, carotid, and femoral plaques 38, 36 and 29 transcripts, respectively, were differentially expressed, of which 25 were shared by the plaques of all arterial beds. Among the most interesting gene-level findings, we observed that transcripts of the integrin gene ITGB2 are highly upregulated mostly in macrophages and T cells while having top centrality in the network and top enriched genesets related to cell junctions. Conclusions This is the first study exploring the association of local complement expression across multiple arterial beds and histologically diverse plaque samples. The local effect of complement-mediated inflammation is indicated in inflammatory plaque tissue but not in smooth muscle cell-dominated plaques. Taken together, gene expression of the complement system components in artery cells is associated with advanced atherosclerosis.

  • Open Access

    Viridans Streptococcal Biofilm Evades Immune Detection and Contributes to Inflammation and Rupture of Atherosclerotic Plaques

    by Pekka J. Karhunen, Tanja Pessi, Sohvi Hörkkö, Vesa Karhunen, Sirkka Goebeler, Anne‐Mari Louhelainen, Mika Martiskainen, Teppo Haapaniemi, Johanna Lappeteläinen, Tommi Ijäs, et al.

    Background: Bacterial DNA from the oral cavity, respiratory tract, gut, and skin has been detected in atherosclerotic plaques, suggesting a role in chronic inflammation linked to atherosclerosis. Chronic bacterial infections often form biofilms resistant to antibiotics and immune detection, giving rise to a new generation of virulent bacteria in suitable conditions. This study explores the role of the immune system in bacterial‐induced inflammation of atherosclerotic plaques. Methods: Coronary plaques from 121 sudden death victims and endarterectomy samples from 96 surgical patients were analyzed using bacterial real‐time quantitative polymerase chain reaction, immunohistochemistry, and genome‐wide expression analysis. TLR (toll‐like receptor) signaling was examined in bacterial‐activated TLR cell lines. Results: Of the bacteria detected, oral viridans group streptococcal DNA was the most common, being found in 42.1% of coronary plaques and 42.9% of endarterectomies. Immunopositivity for viridans streptococci correlated with severe atherosclerosis ( P P =0.021) or myocardial infarction ( P =0.042). Viridans streptococci colonized the core of the atheroma as a biofilm unrecognized by macrophages of the innate immune system. In contrast, immunopositive streptococci that appeared to have originated from the biofilm infiltrated the ruptured fibrous cap of the atheroma in endarterectomy samples and coronary plaques and were detected by pattern‐recognizing receptors and coexpressed with the adaptive immune response. Among the viridans streptococcal strains, TLR2 was the most activated bacterial‐signaling pathway. Genome‐wide expression analysis of endarterectomy samples showed upregulation of bacterial recognition pathways. Conclusions: Latent chronic bacterial inflammation evades immune detection and may contribute to the pathogenesis of complicated atherosclerotic plaques and fatal myocardial infarction.


  • Open Access

    Regulation of nc886 (vtRNA2-1) RNAs is associated with cardiometabolic risk factors and diseases

    by Sonja Rajić, Thomas Delerue, Justiina Ronkainen, Ruiyuan Zhang, Joanna Ciantar, Daria Kostiniuk, Pashupati P. Mishra, Leo-Pekka Lyytikäinen, Nina Mononen, Laura Kananen, et al.

    Non-coding 886 (nc886 , vtRNA2-1) is a polymorphically imprinted gene. The methylation status of this locus has been shown to be associated with periconceptional conditions, and both the methylation status and the levels of nc886 RNAs have been shown to associate with later-life health traits. We have previously shown that nc886 RNA levels are associated not only with the methylation status of the locus, but also with a genetic polymorphism upstream from the locus. In this study, we describe the genetic and epigenetic regulators that predict lifelong nc886 RNA levels, as well as their association with cardiometabolic disease (CMD) risk factors and events. We utilised six population cohorts and one CMD cohort comprising 9058 individuals in total. The association of nc886 RNA levels, as predicted by epigenetic and genetic regulators, with CMD phenotypes was analysed using regression models, with a meta-analysis of the results. The meta-analysis showed that individuals with upregulated nc886 RNA levels have higher diastolic blood pressure (β = 0.07, p = 0.008), lower HDL levels (β = − 0.07, p = 0.006) and an increased incidence of type 2 diabetes (OR = 1.260, p = 0.013). Moreover, CMD patients with upregulated nc886 RNA levels have an increased incidence of stroke (OR = 1.581, p = 0.006) and death (OR = 1.290, p = 0.046). In conclusion, we show that individuals who are predicted to present elevated nc886 RNA levels have poorer cardiovascular health and are at an elevated risk of complications in secondary prevention. This unique mechanism yields metabolic variation in human populations, constituting a CMD risk factor that cannot be modified through lifestyle choices.


  • Open Access

    Commentary on “Epigenome-wide analysis across the development span of pediatric acute lymphoblastic leukemia: backtracking to birth”

    by Emma Raitoharju, Saara Marttila

    VTRNA2-1 is a polymorphically imprinted locus. The proportion of individuals with a maternally imprinted VTRNA2-1 locus is consistently approximately 75% in populations of European origin, with the remaining circa 25% having a non-methylated VTRNA2-1 locus. Recently, VTRNA2-1 hypermethylation at birth was suggested to be a precursor of paediatric acute lymphoblastic leukaemia with biomarker potential. The results presented by Ghantous et al. [1] allow for an alternative interpretation to what the authors discussed, and we argue that the observed methylation difference at birth is due to an uneven distribution of imprinted and non-methylated individuals among the cases and controls, with all individuals presenting normative physiological VTRNA2-1 methylation levels. In addition, the notable interindividual variation arising from the polymorphic imprinting in VTRNA2-1 methylation levels calls into question the validity of VTRNA2-1 methylation as a biomarker.